Written Question·Department of Health and Social Care·UIN 94872
Puberty Suppressing Hormones: Gender Dysphoria
Tabled: 26 November 2025
Answered: 17 December 2025
Question
Rupert Lowe
Restore Britain — Great Yarmouth
To ask the Secretary of State for Health and Social Care, what evidence NICE has identified as the basis for its clinical assessment of puberty blockers for gender dysphoria; and whether NICE has undertaken (a) scoping and (b) evaluation exercises since 2
Answer
Dr Zubir AhmedThe National Institute for Health and Care Excellence (NICE) has not developed guidance on, or made a clinical assessment of, puberty blockers for gender dysphoria. In 2020, NICE developed two evidence summaries:Gonadotrophin releasing hormone analogues f...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 94872) →